HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hyperphosphorylation of CDH1 in Glioblastoma Cancer Stem Cells Attenuates APC/CCDH1 Activity and Pharmacologic Inhibition of APC/CCDH1/CDC20 Compromises Viability.

Abstract
Glioblastoma (GBM) is the most common and lethal primary brain tumor and remains incurable. This is in part due to the cellular heterogeneity within these tumors, which includes a subpopulation of treatment-resistant cells called cancer stem-like cells (CSC). We previously identified that the anaphase-promoting complex/cylosome (APC/C), a key cell-cycle regulator and tumor suppressor, had attenuated ligase activity in CSCs. Here, we assessed the mechanism of reduced activity, as well as the efficacy of pharmacologically targeting the APC/C in CSCs. We identified hyperphosphorylation of CDH1, but not pseudosubstrate inhibition by early mitotic inhibitor 1 (EMI1), as a major mechanism driving attenuated APC/CCDH1 activity in the G1-phase of the cell cycle in CSCs. Small-molecule inhibition of the APC/C reduced viability of both CSCs and nonstem tumor cells (NSTCs), with the combination of proTAME and apcin having the biggest impact. Combinatorial drug treatment also led to the greatest mitotic arrest and chromosomal abnormalities. IMPLICATIONS: Our findings demonstrate how the activity of the APC/CCDH1 tumor suppressor is reduced in CSCs and also validates small-molecule inhibition of the APC/C as a promising therapeutic target for the treatment of GBM.
AuthorsKuntal De, Treg M Grubb, Abigail A Zalenski, Kayla E Pfaff, Debjani Pal, Shubhra Majumder, Matthew K Summers, Monica Venere
JournalMolecular cancer research : MCR (Mol Cancer Res) Vol. 17 Issue 7 Pg. 1519-1530 (07 2019) ISSN: 1557-3125 [Electronic] United States
PMID31036696 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright©2019 American Association for Cancer Research.
Chemical References
  • Antigens, CD
  • CDH1 protein, human
  • Cadherins
  • Carbamates
  • Cdc20 Proteins
  • Cell Cycle Proteins
  • Diamines
  • F-Box Proteins
  • FBXO5 protein, human
  • Small Molecule Libraries
  • apcin
  • CDC20 protein, human
  • Anaphase-Promoting Complex-Cyclosome
Topics
  • Anaphase-Promoting Complex-Cyclosome (antagonists & inhibitors, genetics)
  • Antigens, CD (genetics)
  • Cadherins (antagonists & inhibitors, genetics)
  • Carbamates (pharmacology)
  • Cdc20 Proteins (genetics)
  • Cell Cycle Proteins (genetics)
  • Cell Survival (drug effects, genetics)
  • Diamines (pharmacology)
  • F-Box Proteins (genetics)
  • Glioblastoma (drug therapy, genetics, pathology)
  • Humans
  • Mitosis (drug effects, genetics)
  • Neoplastic Stem Cells (drug effects)
  • Phosphorylation (drug effects)
  • Small Molecule Libraries (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: